Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > T. James Parsons > Profile

T. James Parsons

Affiliations

Director at Diamedica Therapeutics Inc. (DMAC), 2025-06-03
Chief Financial Officer at Trillium Therapeutics Inc. (TRIL), 2021-11-19

Insider Trading: Purchases See All

Symbol	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
DMAC	$4.00	2,250	$9,000.00	6,100	2018-12-11	Filing

Insider Trading: Sales See All

Symbol	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
TRIL	$15.79	8,505	$134,270.99	0	2021-01-08	Filing